Health
Is Semaglutide Safe for Breastfeeding Moms?
Health Points
- Semaglutide, found in Ozempic and Wegovy, is not advised during pregnancy, and its safety during breastfeeding remains unclear.
- Recent small studies found no semaglutide in breast milk, but experts disagree on the risk to infants.
- Current guidelines recommend discussing medication use with your healthcare provider if you are breastfeeding or planning to breastfeed.
Women are advised to stop taking medications like Ozempic and Wegovy two months before becoming pregnant, yet the guidance for breastfeeding is less certain.
Interest in semaglutide use among new mothers has grown rapidly, but experts urge caution because there’s limited research on its effects while nursing.
Does Semaglutide Enter Breast Milk?
Dr. Fatima Cody Stanford firmly recommends against using semaglutide and other GLP-1 medications during breastfeeding. “Just don’t do it,” she states, adding that these drugs haven’t been tested in newborns.
Other specialists, like Dr. Kaytlin Krutsch, point out that semaglutide is a large molecule, making it unlikely to pass into breast milk or be absorbed by infants. “Getting semaglutide in your milk is like fitting an elephant through the kitchen window,” Krutsch explains.
One 2024 study analyzed breast milk samples from women using the drug and detected no trace of semaglutide, suggesting infant exposure may be negligible.
However, some experts caution that research is still in early stages; most available data comes from small groups and short-term observation.
What About Milk Supply?
The effect of semaglutide on milk supply is still unknown. Experts recommend consulting with a healthcare provider before making decisions about medication use while breastfeeding.
When it comes to the health of both mother and baby, staying informed and talking openly with your doctor is your best strategy.
